MetaADEDB 2.0 @ LMMD
Medigoxin
(IYJMSDVSVHDVGT-PEQKVOOWSA-N)
Structure
SMILES
CO[C@H]1[C@@H](O)C[C@@H](O[C@@H]1C)O[C@H]1[C@@H](O)C[C@@H](O[C@@H]1C)O[C@H]1[C@@H](O)C[C@@H](O[C@@H]1C)O[C@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2([C@]1(O)CC[C@@H]2C1=CC(=O)OC1)C)C
Type(s)
Experimental
ATC code(s)
C01AA08
Molecular Formula:
C42H66O14
Molecular Weight:
794.965
Log P:
2.8722
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
5
TPSA:
192.06
CAS Number(s):
30685-43-9
Synonym(s)
1.
Medigoxin
2.
Metildigoxin
3.
beta-Methyldigoxin
4.
4'''-O-Methyldigoxin
5.
Bemecor
6.
Lanirapid
7.
Lanitop
8.
Medixin
9.
Methyldigoxin
10.
4''' O Methyldigoxin
11.
beta Methyldigoxin
External Link(s)
MeSHD008520
PubChem Compound443946
ChEBI135885
CHEMBLCHEMBL1697843
DrugBankDB13401
DrugCentral1761
KEGGdr:D09847
ZINC254011770
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abnormal visionOFFSIDES
2AdenocarcinomaOFFSIDES
3Alanine Aminotransferase IncreasedOFFSIDES
4Alcoholic IntoxicationOFFSIDES
5Altered state of consciousnessOFFSIDES
6AngioplastyOFFSIDES
7AnorexiaOFFSIDES
8AnosmiaOFFSIDES
9AnuriaOFFSIDES
10AnxietyOFFSIDES
11Aortic AneurysmOFFSIDES
12ApathyOFFSIDES
13ApneaOFFSIDES
14AscitesOFFSIDES
15Aspiration PneumoniaOFFSIDES
16AtaxiaOFFSIDES
17Atherosclerosis obliteransOFFSIDES
18Atrial Fibrillation402273
10524732
CTD
19Atrial conduction time prolongationOFFSIDES
20Atrial tachycardiaOFFSIDES
21Autoimmune thrombocytopeniaOFFSIDES
22Bacteria sputum identifiedOFFSIDES
23Blood albumin decreasedOFFSIDES
24Blood chloride decreasedOFFSIDES
25Blood corticotrophin abnormalOFFSIDES
26Blood cortisol increasedOFFSIDES
27Blood creatine phosphokinase increasedOFFSIDES
28Blood creatinine increasedOFFSIDES
29Blood fibrinogen increasedOFFSIDES
30Blood glucose decreasedOFFSIDES
31Blood lactate dehydrogenase increasedOFFSIDES
32Blood phosphorus decreasedOFFSIDES
33Blood potassium increasedOFFSIDES
34Blood pressure immeasurableOFFSIDES
35Blood sodium increasedOFFSIDES
36Blood sodiumOFFSIDES
37Blood thyroid stimulating hormone increasedOFFSIDES
38Blood urea increasedOFFSIDES
39Blood uric acidOFFSIDES
40BradycardiaOFFSIDES
41Brain natriuretic peptide increasedOFFSIDES
42BronchiolitisOFFSIDES
43Cardioactive drug level increasedOFFSIDES
44CardiotoxicityOFFSIDES
45Chemotherapeutic drug level increasedOFFSIDES
46Choking sensationOFFSIDES
47ChoroiditisOFFSIDES
48ChromaturiaOFFSIDES
49CirrhosisOFFSIDES
50Clostridium colitisOFFSIDES
51Colitis erosiveOFFSIDES
52Congenital tricuspid valve incompetenceOFFSIDES
53Corneal abscessOFFSIDES
54CyanosisOFFSIDES
55Delusional disorder, persecutory typeOFFSIDES
56Depressed Level of ConsciousnessOFFSIDES
57Depressed moodOFFSIDES
58Diabetic NephropathyOFFSIDES
59DiarrheaOFFSIDES
60Disease recurrenceOFFSIDES
61Disseminated Intravascular CoagulationOFFSIDES
62Drug administration errorOFFSIDES
63DyslaliaOFFSIDES
64DysuriaOFFSIDES
65Ear discomfortOFFSIDES
66EmbolectomyOFFSIDES
67Embolic strokeOFFSIDES
68EmbolismOFFSIDES
69EndocarditisOFFSIDES
70EndophthalmitisOFFSIDES
71Endotoxic shockOFFSIDES
72EnteritisOFFSIDES
73EnterocolitisOFFSIDES
74EpilepsyOFFSIDES
75EpistaxisOFFSIDES
76Familial Mediterranean FeverOFFSIDES
77Floppy iris syndromeOFFSIDES
78FolliculitisOFFSIDES
79Gamma-Glutamyltransferase IncreasedOFFSIDES
80Gastric ulcerOFFSIDES
81GastroenteritisOFFSIDES
82Gastrointestinal Diseases1845639CTD
83Gastrointestinal perforationOFFSIDES
84General physical conditionOFFSIDES
85General physical health deteriorationOFFSIDES
86GlossectomyOFFSIDES
87HepatitisOFFSIDES
88HypercapniaOFFSIDES
89HypopituitarismOFFSIDES
90Hypothalamo-pituitary disorderOFFSIDES
91HypoxiaOFFSIDES
92Implant tissue necrosisOFFSIDES
93Implantable defibrillator insertionOFFSIDES
94InfectionOFFSIDES
95Infusion site mobility decreasedOFFSIDES
96Injury asphyxiationOFFSIDES
97Intestinal PerforationOFFSIDES
98Kidney FailureOFFSIDES
99Leukopenia neonatalOFFSIDES
100Light chain analysis increasedOFFSIDES
101Lupus-like syndromeOFFSIDES
102Lymphocyte count abnormalOFFSIDES
103Lymphocyte count decreasedOFFSIDES
104Markedly reduced dietary intakeOFFSIDES
105Mechanical ventilationOFFSIDES
106Multiple MyelomaOFFSIDES
107Muscle necrosisOFFSIDES
108MyelodysplasiaOFFSIDES
109Myoglobin blood increasedOFFSIDES
110NauseaOFFSIDES
111Neutrophil count decreasedOFFSIDES
112OrthopneaOFFSIDES
113PallorOFFSIDES
114Pericardial effusionOFFSIDES
115Pericarditis lupusOFFSIDES
116Peripheral embolismOFFSIDES
117Platelet count abnormalOFFSIDES
118PleurisyOFFSIDES
119Prescribed overdoseOFFSIDES
120Protein total decreasedOFFSIDES
121Psychoses, Substance-Induced1669614CTD
122Pulmonary congestionOFFSIDES
123Rectal polypOFFSIDES
124RhabdomyolysisOFFSIDES
125Septic ShockOFFSIDES
126Splenic InfarctionOFFSIDES
127Stasis dermatitisOFFSIDES
128Sudden deathOFFSIDES
129Upper respiratory tract inflammationOFFSIDES
130Urine ketone body presentOFFSIDES
131Vaginal burning sensationOFFSIDES
132Ventricular FibrillationOFFSIDES
133Vitamin A DeficiencyOFFSIDES
134Vocal Cord ParalysisOFFSIDES
135synovial sarcomaOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.